Larvol Delta - AB2100-an-Integrated-Circuit-T-ICT-Cell-Therapy-in-Patients-With-Recurrent-Clearcell-Renal-Cell-Carcinoma-ccRCC

cyclophosphamide - Generic mfg.

AB-2100 - ArsenalBio

http://clinicaltrials.gov/ct2/show/NCT06245915

Feb 7, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next